Predicted to enable RNA 7-methylguanosine cap binding activity; translation initiation factor activity; and ubiquitin protein ligase binding activity. Acts upstream of or within in utero embryonic development. Predicted to be located in P-body. Predicted to be part of eukaryotic translation initiation factor 4F complex and mRNA cap binding activity complex. Is expressed in early conceptus; embryo; primary oocyte; and secondary oocyte. Orthologous to human EIF4E2 (eukaryotic translation initiation factor 4E family member 2). [provided by Alliance of Genome Resources, Apr 2022]